Food & Beverages Global On demand · 24-48h

Global Beta Glucan Market Strategic Research Report

Global Beta Glucan Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Beta Glucan Market
$5402025
7.6%CAGR
2031Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Oat-Derived Beta Glucan, Barley-Derived Beta Glucan, Yeast-Derived Beta-1, 3/1, 6-Glucan, Mushroom-Derived Beta Glucan, Other Sources (Seaweed, Wheat)

By Application: Food & Beverage Fortification, Dietary Supplements & Nutraceuticals, Pharmaceuticals & Clinical Nutrition, Cosmetics & Personal Care, Animal Feed & Aquaculture

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Cargill, Incorporated, Kerry Group plc, Tate & Lyle PLC, DSM-Firmenich AG, Naturex (Givaudan), Lantmännen Oats (Biovelop AB), Biothera Pharmaceuticals (Wellmune), Ohly GmbH (Associated British Foods), Ceapro Inc., Super Beta Glucan Inc.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2031
Length: 150 pages
Market size 2025
$540
Million USD
Forecast CAGR
7.6%
2025-2031
Forecast 2031
$838
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

The global beta glucan market occupies a commercially significant position at the intersection of functional food ingredients, nutraceuticals, and pharmaceutical excipients. Beta glucans are naturally occurring polysaccharides found predominantly in the cell walls of oats, barley, yeast, and certain mushrooms, and they have earned regulatory recognition from bodies including the U.S. Food and Drug Administration and the European Food Safety Authority for their documented capacity to reduce LDL cholesterol and moderate postprandial blood glucose response. Valued at approximately USD 0.54 billion in 2024, the market reflects expanding consumer demand for scientifically validated bioactive ingredients across food and beverage, dietary supplement, cosmetics, and pharmaceutical formulations. The ingredient's versatility across diverse delivery formats — from soluble fiber enrichment in breakfast cereals to immunomodulatory capsules and topical skin-conditioning agents — underpins its sustained commercial relevance across both developed and emerging economies.

Three converging forces are accelerating market expansion. First, the global prevalence of cardiovascular disease and type 2 diabetes has intensified clinical and consumer interest in oat and barley-derived beta glucans, whose cholesterol-lowering efficacy at daily intakes as low as 3 grams is substantiated by over two decades of peer-reviewed research. This epidemiological pressure is translating directly into product development pipelines at major food manufacturers seeking clean-label, fiber-fortified offerings. Second, the immune health supplement category — which expanded sharply during the COVID-19 period — has sustained structural demand for yeast-derived beta-1,3/1,6-glucan in immune support formulations, with clinical evidence linking beta glucan supplementation to enhanced innate immune response against respiratory infections. Third, the cosmetics and personal care sector is increasingly adopting oat-derived beta glucan as a multifunctional skin-conditioning and moisture-retention agent, broadening the ingredient's addressable market well beyond traditional food channels. The principal restraint limiting more rapid market penetration is ingredient cost and supply chain complexity: high-purity beta glucan extraction and fractionation remains technically demanding, and price sensitivity among mid-tier food manufacturers constrains adoption relative to commodity fiber alternatives.

This report provides a comprehensive quantitative and qualitative assessment of the global beta glucan market for the period 2025 through 2032, anchored to a 2024 base year and supported by a 2019–2024 historical review. It covers the full value chain from raw material sourcing through end-use application, segmented by source type, purity grade, application, and geography across all major regions and six key country-level markets. The report profiles ten leading ingredient suppliers and maps the competitive landscape through share analysis, Porter's Five Forces, PESTLE, and SWOT frameworks. Corporate strategy teams evaluating ingredient portfolio expansion, investment analysts assessing nutraceutical ingredient assets, procurement managers benchmarking supplier capabilities, and M&A advisors conducting due diligence on bioactive ingredient platforms will find this research directly actionable.

Market snapshot

Global Beta Glucan Market Strategic Research Report snapshot, 2025–2031

Source: Market Research Reports
Market size CAGR 7.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$540
2025
Forecast
$838
2031
CAGR
7.6%
2025–2031
영역들
5
global
Key companies
CargillIncorporatedKerry Group plcTate & Lyle PLCDSM-Firmenich AGNaturex (Givaudan)Lantmännen Oats (Biovelop AB)Biothera Pharmaceuticals (Wellmune)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Oat-Derived Beta GlucanBarley-Derived Beta GlucanYeast-Derived Beta-13/16-GlucanMushroom-Derived Beta GlucanOther Sources (SeaweedWheat)
By Application
Food & Beverage FortificationDietary Supplements & NutraceuticalsPharmaceuticals & Clinical NutritionCosmetics & Personal CareAnimal Feed & Aquaculture

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value & Volume Forecast (Thousand Metric Tonnes), 2025-2032
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
  • 3.1 Market by Type Overview
  • 3.2 Oat-Derived Beta Glucan (Value & Volume)
  • 3.3 Barley-Derived Beta Glucan (Value & Volume)
  • 3.4 Yeast-Derived Beta-1,3/1,6-Glucan (Value & Volume)
  • 3.5 Mushroom-Derived Beta Glucan (Value & Volume)
  • 3.6 Other Sources (Seaweed, Wheat) (Value & Volume)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Food & Beverage Fortification (Value & Volume)
  • 4.3 Dietary Supplements & Nutraceuticals (Value & Volume)
  • 4.4 Pharmaceuticals & Clinical Nutrition (Value & Volume)
  • 4.5 Cosmetics & Personal Care (Value & Volume)
  • 4.6 Animal Feed & Aquaculture (Value & Volume)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 Asia Pacific (Value & Volume)
  • 5.3 North America (Value & Volume)
  • 5.4 Europe (Value & Volume)
  • 5.5 Middle East & Africa
  • 5.6 Latin America
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 Germany
  • 6.4 China
  • 6.5 Finland & Scandinavia
  • 6.6 Japan
  • 6.7 Canada
07Growth Drivers & Inhibitors
  • 7.1 FDA and EFSA Health Claims Recognition Driving Mainstream Food Fortification
  • 7.2 Rising Cardiovascular Disease Burden Sustaining Clinical-Grade Oat Beta Glucan Demand
  • 7.3 Post-Pandemic Structural Growth in Yeast Beta Glucan-Based Immune Health Supplements
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Cargill, Incorporated — Revenue, Strategy, Key Products
  • 8.2 Kerry Group plc — Revenue, Strategy, Key Products
  • 8.3 Tate & Lyle PLC — Revenue, Strategy, Key Products
  • 8.4 DSM-Firmenich AG — Revenue, Strategy, Key Products
  • 8.5 Naturex (Givaudan) — Revenue, Strategy, Key Products
  • 8.6 Lantmännen Oats (Biovelop AB) — Revenue, Strategy, Key Products
  • 8.7 Biothera Pharmaceuticals (Wellmune) — Revenue, Strategy, Key Products
  • 8.8 Ohly GmbH (Associated British Foods) — Revenue, Strategy, Key Products
  • 8.9 Ceapro Inc. — Revenue, Strategy, Key Products
  • 8.10 Super Beta Glucan Inc. — Revenue, Strategy, Key Products
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 High-Purity Soluble Oat Beta Glucan in Precision Nutrition and Medical Foods
  • 13.2 Fermentation-Derived Yeast Beta Glucan Displacing Extraction-Based Supply Chains
  • 13.3 Beta Glucan Integration into Next-Generation Skin Microbiome and Topical Therapeutics
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the beta glucan market?
The global beta glucan market was valued at approximately USD 0.54 billion in 2024 and is projected to reach approximately USD 0.97 billion by 2032. In volume terms, the market is estimated at around 28 thousand metric tonnes in 2024, expanding to roughly 52 thousand metric tonnes by 2032.
What is the CAGR of the beta glucan market?
The global beta glucan market is forecast to grow at a compound annual growth rate of approximately 7.6% over the period 2025 to 2032, driven by health-claim-backed food fortification, immune health supplement demand, and broadening cosmetic applications.
What is driving growth in the beta glucan market?
Three specific forces are shaping market growth. First, regulatory recognition by the FDA and EFSA of beta glucan's cholesterol-lowering health claims is directly enabling product labeling in functional foods, accelerating reformulation across cereal, bakery, and dairy categories. Second, rising global incidence of cardiovascular disease and metabolic syndrome is sustaining clinical demand for high-purity oat and barley beta glucan in cholesterol management formulations. Third, structural growth in the immune health supplement category — amplified by pandemic-era consumer behavior changes — continues to support yeast-derived beta-1,3/1,6-glucan volumes in capsule and powder supplement formats.
Who are the leading companies in the beta glucan market?
The market features a mix of large diversified ingredient multinationals and specialized bioactive ingredient firms. Cargill and Kerry Group hold strong positions in oat-based food ingredient supply. Tate & Lyle is prominent in functional fiber solutions. DSM-Firmenich competes across nutraceutical and food science segments. Lantmännen's Biovelop subsidiary (producer of OatWell branded oat beta glucan) is a dedicated specialist, while Biothera's Wellmune ingredient platform commands significant share in the yeast beta glucan immune supplement channel.
Which region dominates the beta glucan market?
North America currently holds the largest revenue share of the global beta glucan market, supported by the FDA's long-established qualified health claim for oat beta glucan and cholesterol reduction, a mature functional food and dietary supplement manufacturing base, and high per-capita supplement expenditure. Europe represents the second-largest market, with Scandinavia particularly notable given the region's strong oat cultivation infrastructure and EFSA-approved health claim framework.
What segments are covered in this report?
The report segments the beta glucan market by source type (oat-derived, barley-derived, yeast-derived, mushroom-derived, and other sources including seaweed and wheat), by application (food and beverage fortification, dietary supplements and nutraceuticals, pharmaceuticals and clinical nutrition, cosmetics and personal care, and animal feed and aquaculture), and by geography across five major regions and six country-level markets.
What is the forecast period covered in this report?
This report covers a forecast period from 2025 to 2032, with 2024 as the base year. A historical review spanning 2019 to 2024 is also included to contextualize pre- and post-pandemic demand patterns and supply chain dynamics.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.